Acro Biomedical Co., Ltd.

ACBM

US0048921052

Food Processing

Delayed OTC Markets Other stock markets 18:16:30 15/11/2023 GMT			5-day change	1st Jan Change
0.105 ^USD	-.--%		-.--%	-.--%

2023	Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
2023	Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Acro Biomedical Co., Ltd. Auditor Raises 'Going Concern' Doubt

January 15, 2018

Acro Biomedical Co., Ltd. filed its 10-K on Jan 16, 2018 for the period ending Sep 30, 2017. In this report its auditor, Malone & Bailey, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Latest news about Acro Biomedical Co., Ltd.

Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	02/08/23	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	21/07/23	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21/11/22	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	15/04/22	CI
Acro Biomedical Co., Ltd. Auditor Raises 'Going Concern' Doubt	14/04/22	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	22/11/21	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	23/08/21	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	24/05/21	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	02/04/21	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	17/11/20	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	19/08/20	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	19/05/20	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended December 31, 2019	27/03/20	CI
Acro Biomedical Co., Ltd. Determines to Change the Fiscal Year of the Company from the Year Ending September 30 to the Calendar Year	17/01/20	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended September 30, 2019	07/01/20	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter Ended June 30, 2019	14/08/19	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended March 31, 2019	15/05/19	CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended December 31, 2018	14/02/19	CI
Acro Biomedical Co., Ltd. Announces Earnings Results for the Year Ended September 30, 2018	28/12/18	CI
Acro Biomedical Co., Ltd. Auditor Raises 'Going Concern' Doubt	15/01/18	CI
Arco Biomedical Co., Ltd. will Change its Name to Acro Biomedical Co., Ltd	27/02/17	CI
ACRO Biomedical Co., Ltd Announces Management Changes	01/02/17	CI

Chart Acro Biomedical Co., Ltd.

Duration

Period

More charts

Company Profile

Acro Biomedical Co., Ltd. is principally engaged in the business is the sale of cordyceps related products. The Company is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The Company's business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus, which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The Company is involved in the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers. It sells products in bulk to companies who may use the Company's products as ingredients in their products or sell the products they purchase from the Company to their own customers.

Sector

Food Processing

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
ACRO BIOMEDICAL CO., LTD.	-.--%	6.3M
ZHEJIANG NHU COMPANY LTD.	+13.97%	8.2B
BELLRING BRANDS, INC.	+5.29%	7.61B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+0.60%	5.95B
THE SIMPLY GOOD FOODS COMPANY	-6.04%	3.72B
BYHEALTH CO., LTD	-10.75%	3.57B
XIAMEN KINGDOMWAY GROUP COMPANY	-7.53%	1.27B
HERBALIFE LTD.	-29.55%	1.07B
SIRIO PHARMA CO., LTD.	+14.57%	988M
JAMIESON WELLNESS INC.	-17.90%	789M